NIFTYMIDSMALLHEALTHCARE · NSE
Nifty MidSmall Healthcare
Index · View only — not on the trading terminal
₹54,291.6
+0.71% (+₹381.35)
Prev. close
₹53,910.25
Volume
2,46,86,122
As of
20 Nov 2026
Price history
Analyst sentiment
No analyst stances in this range
0 analyst stances · last 90 days · one per analyst
Try a wider range — no analyst has covered this yet.
Explore by date range →Analyst opinions
Composition
30 stocks
Member stocks, ranked by today's change — biggest gainers first, biggest losers last.
ASTERDM
Aster DM Quality Care Ltd. · Healthcare
₹779.3
+5.41%
NH
Narayana Hrudayalaya Ltd. · Healthcare
₹1,943.7
+3.77%
KIMS
Krishna Institute of Medical Sciences Ltd. · Healthcare
₹795.6
+3.62%
SYNGENE
Syngene International Ltd. · Healthcare
₹451.7
+3.28%
ABBOTINDIA
Abbott India Ltd. · Healthcare
₹26,525
+3.23%
GRANULES
Granules India Ltd. · Healthcare
₹822.65
+2.68%
LALPATHLAB
Dr. Lal Path Labs Ltd. · Healthcare
₹2,006
+2.18%
FORTIS
Fortis Healthcare Ltd. · Healthcare
₹825
+1.87%
ANTHEM
Anthem Biosciences Ltd. · Healthcare
₹951.05
+1.52%
GLENMARK
Glenmark Pharmaceuticals Ltd. · Healthcare
₹2,648
+1.51%
AJANTPHARM
Ajanta Pharmaceuticals Ltd. · Healthcare
₹3,317.7
+1.45%
MANKIND
Mankind Pharma Ltd. · Healthcare
₹2,665
+1.37%
GLAND
Gland Pharma Ltd. · Healthcare
₹3,331.9
+1.18%
ALKEM
Alkem Laboratories Ltd. · Healthcare
₹5,185
+0.78%
LUPIN
Lupin Ltd. · Healthcare
₹2,014
+0.76%
SAILIFE
Sai Life Sciences Ltd. · Healthcare
₹1,800.7
+0.69%
COHANCE
Cohance Lifesciences Ltd. · Healthcare
₹462.3
+0.62%
GLAXO
Glaxosmithkline Pharmaceuticals Ltd. · Healthcare
₹2,727.6
+0.52%
ONESOURCE
Onesource Specialty Pharma Ltd. · Healthcare
₹1,609.3
+0.40%
BIOCON
Biocon Ltd. · Healthcare
₹364.4
+0.21%
MEDANTA
Global Health Ltd. · Healthcare
₹1,480.2
+0.13%
WOCKPHARMA
Wockhardt Ltd. · Healthcare
₹2,184.4
-0.12%
PPLPHARMA
Piramal Pharma Ltd. · Healthcare
₹239.3
-0.15%
AUROPHARMA
Aurobindo Pharma Ltd. · Healthcare
₹1,799
-0.37%
LAURUSLABS
Laurus Labs Ltd. · Healthcare
₹2,294.6
-0.49%
IPCALAB
Ipca Laboratories Ltd. · Healthcare
₹1,843.8
-0.87%
NATCOPHARM
NATCO Pharma Ltd. · Healthcare
₹814.3
-0.93%
POLYMED
Poly Medicure Ltd. · Healthcare
₹1,635.7
-2.09%
NEULANDLAB
Neuland Laboratories Ltd. · Healthcare
₹20,642
-2.18%
ACUTAAS
Acutaas Chemicals Ltd. · Healthcare
₹3,833.5
-3.61%
Index levels are informational only, not investment advice.
Piramal Pharma Share Price Today Down 2.44%: What It Shows
Piramal Pharma shares fell to Rs 189.70, down 2.44% from the prior close of Rs 194.45, after opening near Rs 194.70 and reaching an intraday high of Rs 199.50. The decline occurs amid a large‑cap company reporting a P/B of 3.23x, negative ROE of 4.04% and EPS of Rs ‑2.36, figures that lag industry benchmarks.
How JSW Steel, Dr Reddy’s, Mankind Pharma are fine-tuning AI investments
Mankind Pharma’s global CFO, Ashutosh Dhawan, highlighted the company’s AI strategy at the ETCFO Annual Conclave, stressing the need to balance immediate productivity gains with long‑term capability building. Dhawan noted that Mankind Pharma is prioritising AI projects that deliver measurable operational efficiencies while also investing in foundational data and compliance systems that may not show instant ROI. This dual approach aims to strengthen future competitiveness without compromising current financial discipline.
Acutaas Chemicals falls 3.80% in Friday's session
Global Banking & Finance Review · 2 days ago
Neuland Laboratories falls 2.85% in Friday's session
Global Banking & Finance Review · 2 days ago
UAE ranks joint first globally in personal safety, scores 96% in Gallup Global Safety Report
Gulf News · 2 days ago
Krishna Institute of Medical Sciences (NSE: KIMS) Q2 FY27 Results: Revenue Growth and Margin Trends
Kalkine India · 2 days ago
Max Healthcare, Apollo Hospitals, other healthcare stocks surge over 5% despite volatile market; what’s behind the surge?
Upstox · 3 days ago
BSE Hospitals index soars 3%; Apollo, Max, Narayana Hrudayalaya surge 5%
Business Standard · 3 days ago
Gland Pharma Holders Are Up 93% And Here Is What They Saw
Gland Pharma’s shares have risen about 93% year‑to‑date, reaching roughly ₹3,293 from ₹1,715 at the start of 2026. The rally follows a U.S. FDA approval for a methylprednisolone injectable, which helped lift quarterly revenue to ₹18.34 billion and improve net margin to 15.9%, prompting optimistic fair‑value estimates despite some analysts warning of capacity‑utilisation risks.
Alkem Labs shares fall 2% as US FDA issues warning letter to its Daman manufacturing facility
Upstox · 3 days ago
As Global Health Aid Dries Up, Non-Profit Drug Development Faces New Challenges
Global Health Limited faces a shrinking funding environment as donor governments cut global health budgets, with the Gates Foundation reducing PDP grants by nearly a quarter in 2024 and the UK’s support rising only modestly. This financial squeeze threatens the development pipeline of neglected‑disease medicines, as 12 product development partnerships report nearly 300 candidates in various trial stages. The uncertainty may force a “natural selection” of the most viable partnerships, potentially curtailing progress against malaria, tuberculosis and other tropical diseases.
Piramal Pharma acquisition: Company to buy remaining 26% stake in Yapan Bio
BusinessLine · 4 days ago
Sai Life Sciences rises 2.11% in Wednesday's session
Global Banking & Finance Review · 4 days ago
Granules India falls 2.76% in Wednesday's session
Granules India’s shares declined 2.76% during Wednesday’s trading session. The drop contributed to a broader weakening in the Indian pharmaceutical sector, indicating investor sensitivity to recent earnings reports and market sentiment.